Detalhe da pesquisa
1.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345876
2.
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology
; 166(1): 168-177.e8, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769952
3.
Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study.
Hepatology
; 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349709
4.
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.
Hepatology
; 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381525
5.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478755
6.
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
J Hepatol
; 80(6): 882-891, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340811
7.
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
J Hepatol
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479612
8.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734383
9.
High prevalence and clinical relevance of intrapulmonary vascular dilatations in patients undergoing TIPS implantation.
Clin Gastroenterol Hepatol
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729401
10.
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct-acting antivirals.
Eur J Immunol
; 53(11): e2250291, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515498
11.
Elevation of S2-bound α1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma.
J Viral Hepat
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610115
12.
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis.
J Viral Hepat
; 31(6): 324-341, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619214
13.
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.
Hepatology
; 78(6): 1882-1895, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334496
14.
HDV RNA assays: Performance characteristics, clinical utility, and challenges.
Hepatology
; 2023 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640384
15.
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years.
Liver Int
; 44(1): 228-240, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904316
16.
Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis.
Liver Int
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563728
17.
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
Liver Int
; 44(1): 139-147, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787009
18.
Elevated liver enzymes in a German tertiary-care hospital: Distribution, diagnostic steps and diagnosis groups.
Z Gastroenterol
; 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198801
19.
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Gut
; 72(6): 1186-1195, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977815
20.
Reverse inflammaging: Long-term effects of HCV cure on biological age.
J Hepatol
; 78(1): 90-98, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152762